A. Fabbri et al., UNRESPONSIVENESS OF HEPATIC NITROGEN-METABOLISM TO GLUCAGON-INFUSION IN PATIENTS WITH CIRRHOSIS - DEPENDENCE ON LIVER-CELL FAILURE, Hepatology, 18(1), 1993, pp. 28-35
Glucagon exerts an up-regulatory effect on hepatic nitrogen metabolism
in healthy subjects, but its potential role in the presence of liver
failure is uncertain. The effects of glucagon on urea synthesis and he
patic nitrogen clearance during alanine infusion were studied in five
control subjects and six cirrhotic patients in paired experiments at s
pontaneous glucagon concentrations and at high physiological glucagon
levels (almost-equal-to 300 to 500 pmol . L-1) induced by a 7.5-hr con
tinuous glucagon infusion. In all experiments the urea nitrogen synthe
sis rate increased linearly with increasing alpha-amino-nitrogen conce
ntrations. At spontaneous glucagon concentrations the dynamics of alph
a-amino nitrogen to urea nitrogen conversion (functional hepatic nitro
gen clearance) were significantly reduced in cirrhosis (23.2 +/- 6.7 L
. hr-1 vs. 35.3 +/- 8.0 L . hr-1, p < 0.05) in relation to decreased
liver function. Glucagon superinfusion caused a 63% increase in the dy
namics of the process in controls (57.7 +/- 11.0 L . hr-1; p vs. spont
aneous glucagon, p < 0.01), whereas in cirrhosis it increased on avera
ge by only 15% (26.7 +/- 10.7; p = NS). The glucagon-induced change in
functional hepatic nitrogen clearance significantly correlated with g
alactose elimination capacity and antipyrine clearance (r = 0.905 and
0.964, respectively). Glucagon, in high physiological concentrations a
chieved with glucagon infusion, does not produce significant effects o
n hepatic nitrogen metabolism in cirrhosis. The reduced sensitivity of
the cirrhotic liver to glucagon seems to be dependent on decreased he
patocellular function. These data do not support the role of glucagon
as a ''catabolic'' hormone in cirrhosis.